Recognition of Mtb-infected Cells by CD8+ T Lymphocytes
CD8 T 淋巴细胞对 Mtb 感染细胞的识别
基本信息
- 批准号:8072940
- 负责人:
- 金额:$ 0.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-24 至 2010-09-30
- 项目状态:已结题
- 来源:
- 关键词:Antigen Presentation PathwayAntigen-Presenting CellsAntigensBindingBiological AssayBrefeldin ACD8-Positive T-LymphocytesCD8B1 geneCell FractionationCellsChildClinicalConfocal MicroscopyContainmentCross PresentationCytotoxic T-LymphocytesDataDevelopmentDiseaseEffector CellElectron MicroscopyElementsFrequenciesFundingGeneticGoalsGolgi ApparatusHLA-E antigenHeat shock proteinsHistocompatibilityHumanImmune responseImmune systemIndividualInfectionLocationMass Spectrum AnalysisMemoryModificationMolecularMycobacterium tuberculosisOrganellesPathway interactionsPatternPeptide/MHC ComplexPersonsPhagosomesPost-Translational Protein ProcessingProcessProteinsReagentRecording of previous eventsResearch PersonnelResearch ProposalsSiteSpecificitySystemT cell responseT-Cell ReceptorT-Cell Receptor-Rearrangement Excision DNA CirclesT-LymphocyteTestingTherapeuticThymus GlandTimeLineTuberculosisVaccine DesignVaccinesWorkalpha-beta T-Cell Receptorantigen processingbaseimprovedinhibitor/antagonistmacrophagemutantpathogenprogramsresponsethymocytetraffickingtuberculosis immunity
项目摘要
DESCRIPTION (provided by applicant): Tuberculosis remains an important clinical problem throughout the world. The causative agent of tuberculosis, Mycobacterium tuberculosis (Mtb), is a facultative intracellular pathogen, residing primarily in macrophages. Protective immunity to tuberculosis depends upon the coordinated response of the cellular immune system. Because CD8+ T cells recognize and destroy target cells infected with intracellular pathogens, the CD8+ T cell response may be important for containment of Mtb and elimination of infected cells. Identification and characterization of human cytotoxic T cells may be essential for the understanding of immunity to tuberculosis, and hence may be required for the development of efficacious vaccines and improved therapeutic strategies. In prior work, we have demonstrated that both classically and non-classically restricted, Mtb-specific responses are present in persons infected with Mtb, have demonstrated that CD8+ T cell preferentially recognize heavily infected DC, have demonstrated that non-classically restricted responses comprise a significant fraction of the overall response, and have demonstrated that the non-classical major histocompatibility molecule HLA-E can present Mtb-derived antigen. This work represented the first description of the use of the HLA-lb molecule HLA-E in the recognition of an intracellular pathogen. As a result, the goal of this continuing application is to further our understanding of this antigen recognition system. An increased understanding of this pathway has important implications for understanding the host-response to Mtb, and possibly for improved vaccine design. Thus, this research proposal is focused on defining the mechanisms by which human CD8+ T cells recognize Mtb infected cells.
AIM 1: Determine the relationship of HLA-E restricted T cell responses with TB disease status.
AIM 2: Establish whether or not the Mtb-phagosome is a competent antigen processing organelle
AIM 3: Characterize Mtb-reactive alpha beta TCR expressing thymocytes
描述(由申请人提供):结核病仍然是世界各地的一个重要临床问题。结核病的病原体,结核分枝杆菌(Mtb),是一种兼性细胞内病原体,主要存在于巨噬细胞中。对结核病的保护性免疫取决于细胞免疫系统的协调反应。因为CD 8 + T细胞识别并破坏被细胞内病原体感染的靶细胞,所以CD 8 + T细胞应答对于遏制Mtb和消除感染的细胞可能是重要的。人细胞毒性T细胞的鉴定和表征对于理解结核病的免疫力可能是必不可少的,因此可能需要开发有效的疫苗和改进的治疗策略。在先前的工作中,我们已经证明了经典和非经典限制性的Mtb特异性应答都存在于感染Mtb的人中,已经证明了CD 8 + T细胞优先识别严重感染的DC,已经证明了非经典限制性应答包括总体应答的显著部分,并且已经证明非经典的主要组织相容性分子HLA-E可以呈递Mtb衍生的抗原。这项工作代表了HLA-Ib分子HLA-E在识别细胞内病原体中的用途的首次描述。因此,本持续申请的目标是进一步了解这种抗原识别系统。对这一途径的进一步了解对于理解宿主对结核分枝杆菌的反应具有重要意义,并可能对改进疫苗设计具有重要意义。因此,这项研究计划的重点是确定人类CD 8 + T细胞识别Mtb感染细胞的机制。
目的1:确定HLA-E限制性T细胞应答与结核病病情的关系。
目的2:确定结核分枝杆菌吞噬体是否是一个有能力的抗原加工细胞器
目的3:表征表达Mtb反应性α β TCR的胸腺细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID M. LEWINSOHN其他文献
DAVID M. LEWINSOHN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID M. LEWINSOHN', 18)}}的其他基金
Memory, Phenotype, and Function of TB-reactive Human MR1 Restricted T cells
结核病反应性人 MR1 限制性 T 细胞的记忆、表型和功能
- 批准号:
10329945 - 财政年份:2019
- 资助金额:
$ 0.88万 - 项目类别:
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
肺驻留、MR1 限制性 T 细胞:与接触结核分枝杆菌后不同结果的关联
- 批准号:
10404652 - 财政年份:2018
- 资助金额:
$ 0.88万 - 项目类别:
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
肺驻留、MR1 限制性 T 细胞:与接触结核分枝杆菌后不同结果的关联
- 批准号:
10164711 - 财政年份:2018
- 资助金额:
$ 0.88万 - 项目类别:
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
肺驻留、MR1 限制性 T 细胞:与接触结核分枝杆菌后不同结果的关联
- 批准号:
9593711 - 财政年份:2018
- 资助金额:
$ 0.88万 - 项目类别:
Human MAIT celis in airway mucosal immune responses to intracellular infections
人 MAIT 细胞在气道粘膜对细胞内感染的免疫反应中的作用
- 批准号:
8880108 - 财政年份:2011
- 资助金额:
$ 0.88万 - 项目类别:
Recognition of Mtb-Infected Cells by Non-Classically Restritcted CD8+ T Cells
非经典限制性 CD8 T 细胞对 Mtb 感染细胞的识别
- 批准号:
8195873 - 财政年份:2010
- 资助金额:
$ 0.88万 - 项目类别:
Recognition of Mtb-Infected Cells by Non-Classically Restritcted CD8+ T Cells
非经典限制性 CD8 T 细胞对 Mtb 感染细胞的识别
- 批准号:
7931814 - 财政年份:2010
- 资助金额:
$ 0.88万 - 项目类别:
Recognition of Mtb-Infected Cells by Non-Classically Restritcted CD8+ T Cells
非经典限制性 CD8 T 细胞对 Mtb 感染细胞的识别
- 批准号:
8397519 - 财政年份:2010
- 资助金额:
$ 0.88万 - 项目类别:
Recognition of Mtb-Infected Cells by Non-Classically Restricted CD8+ T Cells
非经典限制性 CD8 T 细胞对 Mtb 感染细胞的识别
- 批准号:
10554259 - 财政年份:2010
- 资助金额:
$ 0.88万 - 项目类别:
Recognition of Mtb-infected Cells by CD8+ T Lymphocytes
CD8 T 淋巴细胞对 Mtb 感染细胞的识别
- 批准号:
8112146 - 财政年份:2010
- 资助金额:
$ 0.88万 - 项目类别:
相似海外基金
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
- 批准号:
10751133 - 财政年份:2023
- 资助金额:
$ 0.88万 - 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
- 批准号:
10696138 - 财政年份:2022
- 资助金额:
$ 0.88万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10663066 - 财政年份:2022
- 资助金额:
$ 0.88万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10537159 - 财政年份:2022
- 资助金额:
$ 0.88万 - 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
- 批准号:
21K08723 - 财政年份:2021
- 资助金额:
$ 0.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10156950 - 财政年份:2021
- 资助金额:
$ 0.88万 - 项目类别:
The role of CX3CR1+ antigen presenting cells in T cell selection and central tolerance"
CX3CR1抗原呈递细胞在T细胞选择和中枢耐受中的作用"
- 批准号:
10631854 - 财政年份:2021
- 资助金额:
$ 0.88万 - 项目类别:
Reprogramming Cancer Cells into Antigen Presenting Cells: Cancer Vaccination with mRNA Enabled by Charge-Altering Releasable Transporters
将癌细胞重编程为抗原呈递细胞:通过改变电荷的可释放转运蛋白实现 mRNA 的癌症疫苗接种
- 批准号:
10153927 - 财政年份:2021
- 资助金额:
$ 0.88万 - 项目类别:
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10331830 - 财政年份:2021
- 资助金额:
$ 0.88万 - 项目类别:
Analysis on detrimental interplay between pathogenic helper T cells, inflammatory antigen-presenting cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis
多发性硬化症慢性发病机制中致病性辅助 T 细胞、炎症抗原呈递细胞和疾病相关小胶质细胞之间的有害相互作用分析
- 批准号:
20K16294 - 财政年份:2020
- 资助金额:
$ 0.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists